Medicines Discovery Catapult: improving collaborative drug discovery in the UK

3
“It’s very critical we believe to put the patient first, not to introduce patients at the time of clinical development when a lot of the understanding and the patient buy-in could have been beneficial upstream,” says Molloy. Credit: Courtesy of Parentingupstream